Regorafenib(755037-03-7)
- Name: Regorafenib
- Synonyms:4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide;
- Molecular Formula:C21H15ClF4N4O3
- Molecular Weight:482.822
- CAS Registry Number:755037-03-7
- EINECS:815-051-1
- Melting Point:206.0 to 210.0 °C
- Water Solubility:DMSO
Other Product
- 57514-09-7/(2,2-Difluoro-1-methylethyl)benzene
- 33890-03-8/4-Aminoisophthalic acid
- 228559-41-9/KI8751
- 1089283-49-7/GSK1904529A
- 172426-86-7/Despropylene Gatifloxacin
- 697761-98-1/(S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
- 55297-97-7/xeof4+
- 1161233-85-7/BTZ043
- 321674-73-1/2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID
- 755037-03-7/Regorafenib
- 459868-92-9/PF-01367338
- 896466-76-5/AT9283
- 135949-98-3/tert-Butyl1-mercapto-3-phenylpropan-2-ylcarbamate
- 841205-47-8/(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
- 135679-88-8/Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide
- 623172-56-5/N2-(1-Oxohexadecyl)-L-lysyl-L-valyl-L-lysine 2,2,2-trifluoroacetate (1:2)
- 823202-99-9/(2S)-beta-Alanyl-L-prolyl-2,4-diamino-N-(phenylmethyl)butanamide acetate
- 868844-74-0/N-Acetyl-L-alpha-glutamyl-L-alpha-glutamyl-L-methionyl-L-glutaminyl-L-arginyl-L-arginyl-L-alanyl-L-alpha-asparagine
- 1012054-59-9/CUDC-101
- 132980-16-6/5-methoxy-6-methyl-2-aminoindan
- 65592-36-1/2-PYRROLIDINOETHYLAMINE 2HCL
- 195877-46-4/methyl 2-(cyclopentylamino)acetate hydrochloride
- 875320-29-9/JNJ-26481585
- 850173-95-4/ADL-5859
- 820959-17-9/N-Acetyl-beta-alanyl-L-histidyl-L-seryl-L-histidine
- 139226-30-5/Darbufelone
- 500904-61-0/Gemfibrozil Related Compound A ,(E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid
- 937799-91-2/Olaparib, KU-0059436
- 848695-25-0/BIIB-021
- 468740-43-4/Insulin-like Growth Factor-1 Receptor Inhibitor
